Both in Surgical Instruments
SkinHealth Systems vs Daxor
Over the past year SKIN returned −60.0% and DXR returned −34.0%; their daily moves had a correlation of 0.03.
SKIN −60.0% DXR −34.0%Growth of $1, one year, split-adjusted
| Metric | SKIN | DXR |
|---|---|---|
| Price | $11.05 | $8.91 |
| Market cap | $72.0M | $52.0M |
| Today | +6.76% | +2.44% |
| 1 month | −5.7% | −13.5% |
| 6 months | −40.8% | −12.1% |
| Year to date | −60.3% | −39.6% |
| 1 year | −59.7% | — |
| Revenue growth (YoY) | −7.8% | +2.3% |
| Gross margin | 68.4% | 52.2% |
| Net margin | −3.7% | −403.2% |
| P/E (TTM) | — | — |
| Price / sales | 0.2× | — |
| Net cash | -$139.1M | $18.7M |
| Dividend yield | — | — |
| Volatility (60d) | 865.5% | 43.0% |
| Short % of float | 0.4% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).